Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Resistance training and cancer survival.

Christensen JF, Spry NA, Galvão DA.

Mayo Clin Proc. 2014 Oct;89(10):1465. doi: 10.1016/j.mayocp.2014.08.001. No abstract available.

PMID:
25282433
[PubMed - in process]
2.

Protocol for the RT Prepare Trial: a multiple-baseline study of radiation therapists delivering education and support to women with breast cancer who are referred for radiotherapy.

Halkett G, O'Connor M, Aranda S, Jefford M, Spry N, Shaw T, Moorin R, Schofield P.

BMJ Open. 2014 Aug 18;4(8):e006116. doi: 10.1136/bmjopen-2014-006116.

PMID:
25138815
[PubMed - in process]
Free PMC Article
3.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.

Denham JW, Joseph D, Lamb DS, Spry NA, Duchesne G, Matthews J, Atkinson C, Tai KH, Christie D, Kenny L, Turner S, Gogna NK, Diamond T, Delahunt B, Oldmeadow C, Attia J, Steigler A.

Lancet Oncol. 2014 Sep;15(10):1076-89. doi: 10.1016/S1470-2045(14)70328-6. Epub 2014 Aug 14.

PMID:
25130995
[PubMed - in process]
4.

Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: Are the results reflected in observed toxicity rates?

Ebert MA, Bulsara M, Haworth A, Kearvell R, Richardson S, Kennedy A, Spry NA, Bydder SA, Joseph DJ, Denham JW.

J Med Imaging Radiat Oncol. 2014 Aug 1. doi: 10.1111/1754-9485.12212. [Epub ahead of print]

PMID:
25082363
[PubMed - as supplied by publisher]
5.

The relationship between BPAQ-derived physical activity and bone density of middle-aged and older men.

Bolam KA, Beck BR, Adlard KN, Skinner TL, Cormie P, Galvão DA, Spry N, Newton RU, Taaffe DR.

Osteoporos Int. 2014 Nov;25(11):2663-8. doi: 10.1007/s00198-014-2797-z. Epub 2014 Jul 4.

PMID:
24993816
[PubMed - in process]
6.

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.

Pearse M, Fraser-Browne C, Davis ID, Duchesne GM, Fisher R, Frydenberg M, Haworth A, Jose C, Joseph DJ, Lim TS, Matthews J, Millar J, Sidhom M, Spry NA, Tang CI, Turner S, Williams SG, Wiltshire K, Woo HH, Kneebone A.

BJU Int. 2014 Mar;113 Suppl 2:7-12. doi: 10.1111/bju.12623.

PMID:
24894850
[PubMed - indexed for MEDLINE]
7.

Maximal exercise testing of men with prostate cancer being treated with androgen deprivation therapy.

Wall BA, Galvão DA, Fatehee N, Taaffe DR, Spry N, Joseph D, Newton RU.

Med Sci Sports Exerc. 2014 Dec;46(12):2210-5. doi: 10.1249/MSS.0000000000000353.

PMID:
24694745
[PubMed - in process]
8.

Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies.

Cormie P, Chambers SK, Newton RU, Gardiner RA, Spry N, Taaffe DR, Joseph D, Hamid MA, Chong P, Hughes D, Hamilton K, Galvão DA.

BMC Cancer. 2014 Mar 18;14:199. doi: 10.1186/1471-2407-14-199.

PMID:
24641777
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer.

Denham JW, Nowitz M, Joseph D, Duchesne G, Spry NA, Lamb DS, Matthews J, Turner S, Atkinson C, Tai KH, Gogna NK, Kenny L, Diamond T, Smart R, Rowan D, Moscato P, Vimieiro R, Woodfield R, Lynch K, Delahunt B, Murray J, D'Este C, McElduff P, Steigler A, Kautto A, Ball J.

BJU Int. 2014 Sep;114(3):344-53. doi: 10.1111/bju.12497. Epub 2014 Feb 11.

PMID:
24512527
[PubMed - indexed for MEDLINE]
10.

Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.

Cormie P, Galvão DA, Spry N, Joseph D, Chee R, Taaffe DR, Chambers SK, Newton RU.

BJU Int. 2014 Jan 27. doi: 10.1111/bju.12646. [Epub ahead of print]

PMID:
24467669
[PubMed - as supplied by publisher]
11.

Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study.

Cormie P, Galvão DA, Spry N, Joseph D, Taaffe DR, Newton RU.

Support Care Cancer. 2014 Jun;22(6):1537-48. doi: 10.1007/s00520-013-2103-1. Epub 2014 Jan 15.

PMID:
24424484
[PubMed - indexed for MEDLINE]
12.

Serum procollagen 1 amino-terminal propeptide (P1NP) in prostate cancer: pitfalls of its use as an early surrogate marker for bone metastasis.

Moseshvili E, Joseph DJ, Spry NA, Cohen RJ, Abreu A, Kautto A, Denham JW.

J Med Imaging Radiat Oncol. 2014 Aug;58(4):497-502. doi: 10.1111/1754-9485.12134. Epub 2014 Jan 13.

PMID:
24418365
[PubMed - in process]
13.

Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer.

Buffart LM, Galvão DA, Chinapaw MJ, Brug J, Taaffe DR, Spry N, Joseph D, Newton RU.

Cancer. 2014 Jan 15;120(2):294-301. doi: 10.1002/cncr.28396. Epub 2013 Oct 7.

PMID:
24122296
[PubMed - indexed for MEDLINE]
14.

Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer.

Chang D, Joseph DJ, Ebert MA, Galvão DA, Taaffe DR, Denham JW, Newton RU, Spry NA.

J Med Imaging Radiat Oncol. 2014 Apr;58(2):223-8. doi: 10.1111/1754-9485.12124. Epub 2013 Oct 7.

PMID:
24118850
[PubMed - in process]
15.

Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy.

Beydoun N, Bucci JA, Chin YS, Spry N, Newton R, Galvão DA.

J Med Imaging Radiat Oncol. 2014 Jun;58(3):369-76. doi: 10.1111/1754-9485.12115. Epub 2013 Oct 4.

PMID:
24118798
[PubMed - in process]
16.

A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.

Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, Lamb DS, Chambers SK, Newton RU.

Eur Urol. 2014 May;65(5):856-64. doi: 10.1016/j.eururo.2013.09.041. Epub 2013 Oct 3.

PMID:
24113319
[PubMed - indexed for MEDLINE]
17.

Exercise therapy for sexual dysfunction after prostate cancer.

Cormie P, Newton RU, Taaffe DR, Spry N, Galvão DA.

Nat Rev Urol. 2013 Dec;10(12):731-6. doi: 10.1038/nrurol.2013.206. Epub 2013 Oct 8. Review.

PMID:
24100515
[PubMed - indexed for MEDLINE]
18.

Exercise as medicine in the management of pancreatic cancer: a case study.

Cormie P, Spry N, Jasas K, Johansson M, Yusoff IF, Newton RU, Galvão DA.

Med Sci Sports Exerc. 2014 Apr;46(4):664-70. doi: 10.1249/MSS.0000000000000160.

PMID:
24042308
[PubMed - in process]
19.

Radiotherapy of abdomen with precise renal assessment with SPECT/CT imaging (RAPRASI): design and methodology of a prospective trial to improve the understanding of kidney radiation dose response.

Lopez-Gaitan J, Ebert MA, Robins P, Boucek J, Leong T, Willis D, Bydder S, Podias P, Waters G, O'Mara B, Chu J, Faggian J, Williams L, Hofman MS, Spry NA.

BMC Cancer. 2013 Aug 10;13:381. doi: 10.1186/1471-2407-13-381.

PMID:
23937668
[PubMed - in process]
Free PMC Article
20.

Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases.

Cormie P, Newton RU, Spry N, Joseph D, Taaffe DR, Galvão DA.

Prostate Cancer Prostatic Dis. 2013 Dec;16(4):328-35. doi: 10.1038/pcan.2013.22. Epub 2013 Aug 6.

PMID:
23917308
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk